These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9785275)

  • 1. The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure.
    Kita H; Ohi M; Chin K; Noguchi T; Otsuka N; Tsuboi T; Itoh H; Nakao K; Kuno K
    J Sleep Res; 1998 Sep; 7(3):199-207. PubMed ID: 9785275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea.
    Krieger J; Follenius M; Sforza E; Brandenberger G; Peter JD
    Clin Sci (Lond); 1991 May; 80(5):443-9. PubMed ID: 1851683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diurnal and nocturnal diuresis and natriuresis in obstructive sleep apnea. Effects of nasal continuous positive airway pressure therapy.
    Rodenstein DO; D'Odemont JP; Pieters T; Aubert-Tulkens G
    Am Rev Respir Dis; 1992 Jun; 145(6):1367-71. PubMed ID: 1596005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual effect of nCPAP applied for part of the night in patients with obstructive sleep apnoea.
    Hers V; Liistro G; Dury M; Collard P; Aubert G; Rodenstein DO
    Eur Respir J; 1997 May; 10(5):973-6. PubMed ID: 9163633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal autonomic stress responses in obstructive sleep apnoea are reversed by nasal continuous positive airway pressure.
    Veale D; Pépin JL; Wuyam B; Lévy PA
    Eur Respir J; 1996 Oct; 9(10):2122-6. PubMed ID: 8902477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma brain natriuretic peptide in obstructive sleep apnea.
    Svatikova A; Shamsuzzaman AS; Wolk R; Phillips BG; Olson LJ; Somers VK
    Am J Cardiol; 2004 Aug; 94(4):529-32. PubMed ID: 15325948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure.
    Krieger J; Laks L; Wilcox I; Grunstein RR; Costas LJ; McDougall JG; Sullivan CE
    Clin Sci (Lond); 1989 Oct; 77(4):407-11. PubMed ID: 2530023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of nocturnal diuresis and natriuresis during treatment of obstructive sleep apnea (OSA) with nasal continuous positive air pressure (nCPAP) correlates to cGMP excretion.
    Ehlenz K; Firle K; Schneider H; Weber K; Peter JH; Kaffarnik H; von Wichert P
    Med Klin (Munich); 1991 Jun; 86(6):294-6, 332. PubMed ID: 1653395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal continuous positive airway pressure with supplemental oxygen in coexistent sleep apnoea-hypopnoea syndrome and severe chronic obstructive pulmonary disease.
    Sampol G; Sagalés MT; Roca A; de la Calzada MD; Bofill JM; Morell F
    Eur Respir J; 1996 Jan; 9(1):111-6. PubMed ID: 8834343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome.
    Shimizu K; Chin K; Nakamura T; Masuzaki H; Ogawa Y; Hosokawa R; Niimi A; Hattori N; Nohara R; Sasayama S; Nakao K; Mishima M; Nakamura T; Ohi M
    Thorax; 2002 May; 57(5):429-34. PubMed ID: 11978920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NT-pro-BNP in obstructive sleep apnea syndrome is decreased by nasal continuous positive airway pressure.
    Tasci S; Manka R; Scholtyssek S; Lentini S; Troatz C; Stoffel-Wagner B; Lüderitz B
    Clin Res Cardiol; 2006 Jan; 95(1):23-30. PubMed ID: 16598442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide levels and pulmonary artery pressure awake, at exercise and asleep in obstructive sleep apnoea syndrome.
    Schäfer H; Ehlenz K; Ewig S; Hasper E; Koehler U; Latzelsberger J; Tasci S; Lüderitz B
    J Sleep Res; 1999 Sep; 8(3):205-10. PubMed ID: 10476007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of atrial natriuretic factor in moderate to severe obstructive sleep apnea syndrome.
    Lin CC; Tsan KW; Lin CY
    Sleep; 1993 Jan; 16(1):37-9. PubMed ID: 8456234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome.
    Baruzzi A; Riva R; Cirignotta F; Zucconi M; Cappelli M; Lugaresi E
    Sleep; 1991 Feb; 14(1):83-6. PubMed ID: 1839810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the therapy and pathophysiology of patients with obstructive sleep apnoea syndrome.
    Chin K; Ohi M
    Respirology; 1998 Jun; 3(2):139-43. PubMed ID: 9692524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of moderate alcohol consumption on obstructive sleep apnoea with and without AutoSet nasal CPAP therapy.
    Teschler H; Berthon-Jones M; Wessendorf T; Meyer HJ; Konietzko N
    Eur Respir J; 1996 Nov; 9(11):2371-7. PubMed ID: 8947088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic peptide levels in the sleep apnoea/hypopnoea syndrome.
    Mackay TW; Fitzpatrick MF; Freestone S; Lee MR; Douglas NJ
    Thorax; 1994 Sep; 49(9):920-1. PubMed ID: 7940435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription of nCPAP and nBIPAP in obstructive sleep apnoea syndrome: Italian experience in 105 subjects. A prospective two centre study.
    Resta O; Guido P; Picca V; Sabato R; Rizzi M; Scarpelli F; Sergi M
    Respir Med; 1998 Jun; 92(6):820-7. PubMed ID: 9850365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of short term graded withdrawal of nasal continuous positive airway pressure on systemic blood pressure in patients with obstructive sleep apnoea.
    Stradling JR; Partlett J; Davies RJ; Siegwart D; Tarassenko L
    Blood Press; 1996 Jul; 5(4):234-40. PubMed ID: 8809375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP).
    Bratel T; Wennlund A; Carlström K
    Respir Med; 1999 Jan; 93(1):1-7. PubMed ID: 10464840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.